Your browser doesn't support javascript.
loading
Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis.
Berthold, E; Månsson, B; Gullstrand, B; Geborek, P; Saxne, T; Bengtsson, A A; Kahn, R.
Afiliação
  • Berthold E; a Department of Rheumatology, Clinical Sciences Lund , Lund University and Skåne University Hospital , Lund , Sweden.
  • Månsson B; a Department of Rheumatology, Clinical Sciences Lund , Lund University and Skåne University Hospital , Lund , Sweden.
  • Gullstrand B; a Department of Rheumatology, Clinical Sciences Lund , Lund University and Skåne University Hospital , Lund , Sweden.
  • Geborek P; a Department of Rheumatology, Clinical Sciences Lund , Lund University and Skåne University Hospital , Lund , Sweden.
  • Saxne T; a Department of Rheumatology, Clinical Sciences Lund , Lund University and Skåne University Hospital , Lund , Sweden.
  • Bengtsson AA; a Department of Rheumatology, Clinical Sciences Lund , Lund University and Skåne University Hospital , Lund , Sweden.
  • Kahn R; b Department of Pediatrics, Clinical Sciences Lund , Lund University and Skåne University Hospital , Lund , Sweden.
Scand J Rheumatol ; 47(1): 22-26, 2018 Jan.
Article em En | MEDLINE | ID: mdl-28485187

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Fator de Necrose Tumoral alfa / Antirreumáticos / Etanercepte Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Fator de Necrose Tumoral alfa / Antirreumáticos / Etanercepte Idioma: En Ano de publicação: 2018 Tipo de documento: Article